Century Therapeutics Inc Forecast, price target & analysts
$2.55
0.79%
Nasdaq,
Jun 28, 10:21 pm CET
Century Therapeutics Inc Target price 2024 - Analyst rating & recommendation
Powered by
Century Therapeutics Inc Classifications & Recommendation:
Buy
80%
Hold
20%
Century Therapeutics Inc Target price
| Target price | $10.25 |
| Course | $2.55 |
| Price potential |
301.96%
register free of charge
|
| Number of estimates | 4 |
|
4 Analysts have issued a price target Century Therapeutics Inc 2025 .
The average Century Therapeutics Inc target price is $10.25.
This is
301.96%
register free of charge
$12.00
370.59%
register free of charge
$6.00
135.29%
register free of charge
|
|
| A rating was issued by 5 analysts: 4 Analysts recommend Century Therapeutics Inc to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst estimates: Analysts believe that the Century Therapeutics Inc share has an average upside potential 2025 of
301.96%
register free of charge
|
Sales and margin forecast 2024, 2025 to 2028
Create a premium account to unlock analyst estimates.
Learn more
Powered by
Quarter
Annually
| Dec '23 |
2024 Forecast |
|
|---|---|---|
| Turnover Million $ | 2.24 | 2.12 |
| 56.92% | 5.22% | |
| Net margin | -6,654.60% | -5,342.32% |
| 135.21% | 19.72% |
5 Analysts have issued a sales forecast Century Therapeutics Inc 2024 . The average Century Therapeutics Inc sales estimate is
$2.1m
unlock
54.96%
higher
unlock
$3.9m
181.39%
unlock
$900k
34.31%
unlock
This results in the following potential growth figures:
Earnings per share, P/E ratio and EV/sales forecast 2024, 2025 to 2028
Create a premium account to unlock analyst estimates.
Learn more
Powered by
| Dec '23 |
2024 Forecast |
|
|---|---|---|
| Earnings per share $ | -2.30 | -1.75 |
| 1.32% | 23.91% | |
| P/E ratio | negative | |
| EV/Sales | 32.94 |
Based on analysts' sales estimates for 2024, the Century Therapeutics Inc share is valued at an <a href=/blog/ev-sales-einfach-erklaert>EV/Sales of
32.94
unlock
101.50
unlock
This results in the following potential growth figures and future valuations:
Century Therapeutics Inc...
Discover more stocks with a high price target
Register for free
StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.
